Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
November 30, 2023 04:47 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 30. november 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har forhøjet sin aktiekapital med nominelt DKK 1.692.300 som følge af medarbejderes udnyttelse af...
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
November 30, 2023 04:47 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 30, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 1,692,300 as a consequence of employees’...
Bavarian Nordic to hold Capital Markets Days in February 2024
November 22, 2023 12:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 22, 2023 – Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in February 2024 for investors and analysts across Europe and the U.S. At...
Bavarian Nordic to hold Capital Markets Days in February 2024
November 22, 2023 12:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 22, 2023 – Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in February 2024 for investors and analysts across Europe and the U.S. At...
Bavarian Nordic offentliggør delårsregnskab for de første ni måneder af 2023
November 16, 2023 01:37 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 16. november 2023 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab for de første ni måneder af 2023 samt rapporterede på begivenheder for tredje kvartal 2023. ...
Bavarian Nordic Announces Interim Results for the First Nine Months of 2023
November 16, 2023 01:37 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 16, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2023 and business progress for the third quarter of...
Bavarian Nordics mpox-vaccine anbefales til rutinemæssig brug i risikogrupper af de amerikanske sundhedsmyndigheders rådgivningskomité
October 25, 2023 14:03 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 25. oktober 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at den rådgivende vaccinekomité (ACIP) hos det det amerikanske center for infektionsforebyggelse og folkesundhed...
Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk
October 25, 2023 14:03 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, October 25, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices...
Bavarian Nordic tildelt yderligere kontrakt om levering af koppevacciner til strategisk lager i EU
September 13, 2023 05:33 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. september 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået yderligere en kontrakt til en værdi af mere end EUR 11 mio. på levering af MVA-BN®...
Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve
September 13, 2023 05:33 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, September 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract valued at more than EUR 11 million to supply its MVA-BN® smallpox...